CD99 and acute lymphoblastic leukemia: In 2022, human IgG-based tetravalent antibody 10A1 against CD99 residues 63–76 was produced and demonstrated the induction of cell apoptosis in T-ALL patient samples and T-ALL cell lines but not in healthy peripheral blood cells [14].